Asterias Biotherapeutics Stock Fundamentals
Asterias Biotherapeutics fundamentals help investors to digest information that contributes to Asterias Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Asterias Stock. The fundamental analysis module provides a way to measure Asterias Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asterias Biotherapeutics stock.
Asterias |
Asterias Biotherapeutics Company Shares Outstanding Analysis
Asterias Biotherapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Asterias Biotherapeutics Shares Outstanding | 55.66 M |
Most of Asterias Biotherapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asterias Biotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Asterias Biotherapeutics has 55.66 M of shares currently outstending. This is 69.17% lower than that of the sector and 47.91% lower than that of the Shares Outstanding industry. The shares outstanding for all United States stocks is 90.27% higher than that of the company.
Asterias Biotherapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Asterias Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Asterias Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Asterias Biotherapeutics competition to find correlations between indicators driving Asterias Biotherapeutics's intrinsic value. More Info.Asterias Biotherapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Asterias Biotherapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Asterias Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asterias Biotherapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Asterias Biotherapeutics could also be used in its relative valuation, which is a method of valuing Asterias Biotherapeutics by comparing valuation metrics of similar companies.Asterias Biotherapeutics is currently under evaluation in shares outstanding category among its peers.
Asterias Fundamentals
| Return On Equity | -93.17 | |||
| Return On Asset | -0.68 | |||
| Profit Margin | (4.60) % | |||
| Current Valuation | 40.31 M | |||
| Shares Outstanding | 55.66 M | |||
| Shares Owned By Insiders | 40.33 % | |||
| Shares Owned By Institutions | 13.75 % | |||
| Number Of Shares Shorted | 409.74 K | |||
| Price To Earning | (3.41) X | |||
| Price To Book | 2.02 X | |||
| Price To Sales | 67.77 X | |||
| Revenue | 731 K | |||
| Gross Profit | 3.88 M | |||
| EBITDA | (41.26 M) | |||
| Net Income | (20.3 M) | |||
| Cash And Equivalents | 12.59 M | |||
| Cash Per Share | (0.61) X | |||
| Total Debt | 16 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 6.50 X | |||
| Book Value Per Share | 1.16 X | |||
| Cash Flow From Operations | (15.82 M) | |||
| Short Ratio | 2.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Number Of Employees | 31 | |||
| Beta | 3.73 | |||
| Market Capitalization | 52.6 M | |||
| Total Asset | 66.98 M | |||
| Retained Earnings | (59.85 M) | |||
| Working Capital | 19.54 M | |||
| Current Asset | 29.79 M | |||
| Current Liabilities | 10.25 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Asterias Stock
If you are still planning to invest in Asterias Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asterias Biotherapeutics' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |